Drotrecogin Alfa (Activated) in Septic Shock

被引：0
|
作者：
Nayyar, Vineet [1 ]
Solano, Thomas [1 ]
机构：
[1] Westmead Hosp, Westmead, NSW 2145, Australia
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2012年 / 367卷 / 10期
关键词：
PROTEIN-C; RETROSPECTIVE ANALYSIS; PURPURA FULMINANS; SEPSIS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：968 / 969
页数：2
相关论文
共 50 条
  • [21] Drotrecogin Alf (activated) in severe sepsis and septic shock
    Hussain, Aziza Muhammad
    ANAESTHESIA PAIN & INTENSIVE CARE, 2011, 15 (02) : 79 - 80
  • [22] Reversal of refractory septic shock with drotrecogin alpha (activated)
    A. Vieillard-Baron
    V. Caille
    C. Charron
    G. Belliard
    P. Aegerter
    B. Page
    F. Jardin
    Intensive Care Medicine, 2009, 35 : 1204 - 1209
  • [23] Reversal of refractory septic shock with drotrecogin alpha (activated)
    Vieillard-Baron, A.
    Caille, V.
    Charron, C.
    Belliard, G.
    Aegerter, P.
    Page, B.
    Jardin, F.
    INTENSIVE CARE MEDICINE, 2009, 35 (07) : 1204 - 1209
  • [24] An updated meta-analysis to understand the variable efficacy of drotrecogin alfa (activated) in severe sepsis and septic shock
    Lai, P. S.
    Matteau, A.
    Iddriss, A.
    Hawes, C. L.
    Ranieri, V. M.
    Thompson, B. T.
    MINERVA ANESTESIOLOGICA, 2013, 79 (01) : 33 - 43
  • [25] Initiation of drotrecogin alfa (activated) [DTAA] versus placebo infusion acutely improves hemodynamics in patients with septic shock
    Thomas, Joss J.
    Tidswell, Mark
    Shah, Archan
    Octaviani, Raul
    Kozikowski, Krystal
    Nathanson, Brian
    Steingrub, Jay
    CHEST, 2006, 130 (04) : 149S - 150S
  • [26] Three years experience with drotrecogin alfa (activated) protein C in severe sepsis and septic shock at Salmaniya Medical Complex, Bahrain
    H Mohamed
    AA Hameed
    M Al-Ansari
    Critical Care, 11 (Suppl 2):
  • [27] The safety profile of drotrecogin alfa (activated)
    Roberto Fumagalli
    Mariano A Mignini
    Critical Care, 11
  • [28] Drotrecogin alfa (activated) in severe sepsis
    Baillie, JK
    Murray, G
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01): : 95 - 95
  • [29] The safety profile of drotrecogin alfa (activated)
    Fumagalli, Roberto
    Mignini, Mariano A.
    CRITICAL CARE, 2007, 11 (Suppl 5):
  • [30] Effect of Drotrecogin alfa (activated) on Cytokeratin-18 levels in blood of septic patients
    Hoffmann, U.
    Behnes, M.
    Saur, J.
    Lang, S.
    Liebetrau, C.
    Borggrefe, M.
    INFECTION, 2011, 39 : S119 - S119
12345